However, there is currently a lack of studies directly comparing the ability of hs-cTn-I and BNP to predict long-term adverse outcomes, such as heart failure and cardiac death, in patients with idiopathic DCM. The gene discussed is TNNI3; the disease is familial dilated cardiomyopathy.